Vaccine Adjuvants Industry Forecast 2025 – Your Guide to Growth Through 2034

 We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

 
 What is the projected value of the vaccine adjuvants market by 2029?
 The vaccine adjuvants market size has grown strongly in recent years. It will grow from$1.89 billion in 2024 to $2.03 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increasing vaccine development, prevalence of infectious diseases, government initiatives and immunization programs, research and development investments, globalization of vaccine distribution
 
 The vaccine adjuvants market size is expected to see strong growth in the next few years. It will grow to “$2.89 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to pandemic preparedness, expanding vaccine portfolio, global immunization goals, collaborations and partnerships, focus on therapeutic vaccines. Major trends in the forecast period include advancements in adjuvant technologies, focus on immunogenicity enhancement, combination adjuvants for enhanced effectiveness, demand for safer and well-tolerated adjuvants, personalized vaccines and adjuvants.
 
 Download Your Free Sample PDF:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=10121&type=smp
 
 How are technological advancements fueling growth in the vaccine adjuvants market?
 The rising prevalence of infectious diseases is expected to propel the growth of the vaccine adjuvants market going forward. Infectious diseases refer to infections caused by viruses, bacteria, fungi, or parasites. Vaccines are used to treat these infectious diseases such as hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis. For instance, according to the 2022 World Health Organization (WHO) report, an estimated 10.6 million people are infected with tuberculosis globally in 2021, 1.6 million died, and 1.5 million people acquired HIV in 2021 while 650,000 people lost their lives due to it. Therefore, the rising prevalence of infectious diseases will drive the vaccine adjuvants market.
 
 Which segment currently leads the vaccine adjuvants market in terms of revenue share?
 The vaccine adjuvants market covered in this report is segmented –
 
 1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types
 2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants
 3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal
 4) By Disease: Cancer, Infectious Diseases, Other Diseases
 
 Subsegments:
 1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions
 2) By Pathogen Components: Bacterial Components, Viral Components
 3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles
 4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems
 5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants
 
 View The Full Market Report:
 https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report
 
 What evolving trends are creating new opportunities in the vaccine adjuvants market?
 Product innovations are a key trend gaining popularity in the vaccine adjuvants market. Companies operating in the vaccine adjuvants market are focusing on adopting innovative solutions to strengthen their market position in the market. For instance, in December 2022, Evonik Industries, a Germany-based chemical manufacturing company, introduced PhytoSquene, a plant-based squalene derived from amaranth oil. This sustainable alternative to traditional shark-derived squalene is designed for use in vaccine adjuvants and other pharmaceutical applications, enhancing vaccine efficacy by boosting immune responses. The development of PhytoSquene underscores the growing emphasis on sustainability in the pharmaceutical sector.
 
 Who are the top competitors in the global vaccine adjuvants market?
 Major companies operating in the vaccine adjuvants market include GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation
 
 What regional dynamics are shaping the future of the global vaccine adjuvants market?
 North America was the largest region in the vaccine adjuvants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
 
 How Can Companies Use The Vaccine Adjuvants Market Report to Drive Business Results?
 This report provides actionable insights tailored for business use — not academic analysis. Companies can leverage the data to:
 • Time market entry or expansion using growth forecasts and CAGR trends.
 • Develop competitive products by tracking key technology shifts and user preferences.
 • Tailor regional strategies with in-depth geographic data and local market dynamics.
 • Benchmark and plan partnerships using competitive landscape insights.
 
 Purchase The Report And Get A Swift Delivery:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10121
 
 Need Customized Data On Vaccine Adjuvants Market?
 For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
 
 Request Customized Data:
 https://www.thebusinessresearchcompany.com/customise?id=10121&type=smp
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Europe: +44 207 1930 708
 
 Asia: +91 88972 63534
 
 Americas: +1 315 623 0293
 
 Email: info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company